Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Study in Women With Idiopathic Menorrhagia to Determine the Reduction in Menstrual Blood Loss (MBL) After Treatment With the Levonorgestrel-releasing Intrauterine System (IUS)

ClinicalTrials.gov ID: NCT00360490

Public ClinicalTrials.gov record NCT00360490. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 4:22 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Open Label, Parallel Group, Active Control Study to Evaluate the Efficacy and Safety of LNG IUS (Mirena®) as Compared to Medroxyprogesterone Acetate During 6 Cycles of Treatment in Patients With Idiopathic Menorrhagia

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to determine whether the levonorgestrel-releasing intrauterine system is effective in decreasing menstrual blood loss.

Study identification

NCT ID
NCT00360490
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Bayer
Industry
Enrollment
165 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 2006 (Type not available)
Primary completion
Jun 2008 (Actual)
Completion
Jun 2008 (Actual)
Last update posted
Dec 9, 2013

2006 – 2008

United States locations

U.S. sites
37
U.S. states
23
U.S. cities
35
Facility City State ZIP Site status
Not listed Tucson Arizona 85712 —
Not listed Beverly Hills California 90211 —
Not listed Carmichael California 95608 —
Not listed San Diego California 92103 —
Not listed San Diego California 92108 —
Not listed Santa Monica California 90403 —
Not listed Torrance California 90509 —
Not listed Littleton Colorado 80122 —
Not listed Boynton Beach Florida 33437 —
Not listed Jacksonville Florida 32216 —
Not listed West Palm Beach Florida 33409 —
Not listed Boise Idaho 83702 —
Not listed Chicago Illinois 60612 —
Not listed Newburgh Indiana 47630 —
Not listed South Bend Indiana 46601 —
Not listed Amite Louisiana 70422 —
Not listed Marrero Louisiana 70072 —
Not listed Boston Massachusetts 02118 —
Not listed Saginaw Michigan 48602 —
Not listed Chesterfield Missouri 63017 —
Not listed Lincoln Nebraska 68510 —
Not listed Las Vegas Nevada — —
Not listed LasVegas Nevada 89106 —
Not listed Moorestown New Jersey 08057 —
Not listed New Brunswick New Jersey 08901 —
Not listed Winston-Salem North Carolina 27103 —
Not listed Medford Oregon 97504 —
Not listed Portland Oregon 97239 —
Not listed Philadelphia Pennsylvania 19114 —
Not listed Pittsburgh Pennsylvania 15206 —
Not listed Columbia South Carolina 29201 —
Not listed Clarksville Tennessee 37043 —
Not listed Houston Texas 77030 —
Not listed Houston Texas — —
Not listed Burlington Vermont 05401 —
Not listed Norfolk Virginia 23507 —
Not listed Seattle Washington 98105 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 17 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00360490, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 9, 2013 · Synced Oct 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00360490 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →